Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,084 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study of daily carboplatin plus irradiation followed by durvalumab therapy for older adults (≥75 years) with unresectable III non-small-cell lung cancer and performance status of 2: NEJ039A.
Mouri A, Kisohara A, Morita R, Ko R, Nakagawa T, Makiguchi T, Isobe K, Ishikawa N, Kondo T, Akiyama M, Bessho A, Honda R, Yoshimura K, Kagamu H, Kato S, Kobayashi K, Kaira K, Maemondo M. Mouri A, et al. Among authors: isobe k. ESMO Open. 2024 Oct;9(10):103939. doi: 10.1016/j.esmoop.2024.103939. Epub 2024 Oct 11. ESMO Open. 2024. PMID: 39395258 Free PMC article. Clinical Trial.
MGMT protein expression is a reliable predictive biomarker for temozolomide-containing chemotherapy in osteosarcoma.
Uchihara Y, Umeda K, Yamada Y, Ito H, Tasaka K, Isobe K, Akazawa R, Kawabata N, Saida S, Kato I, Hiramatsu H, Noguchi T, Sakamoto A, Arakawa Y, Arakawa A, Yamamoto N, Hosoya Y, Uemura S, Watanabe KI, Sano H, Taga T, Takita J. Uchihara Y, et al. Among authors: isobe k. Cancer Sci. 2024 Oct;115(10):3394-3402. doi: 10.1111/cas.16297. Epub 2024 Jul 30. Cancer Sci. 2024. PMID: 39080996 Free PMC article.
1,084 results